Invitae Corp Overview
Pro stress-test →Invitae Corp operates as a genetic information company offering diagnostic and research tests that include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. The company provides genetic sequencing and genome management platforms for clinical diagnostics and research applications.
Strategic Profile
Pro stress-test →Since July 2022, Invitae has strategically realigned operations to prioritize core genome sequencing and genome management platforms, involving workforce reduction and exiting distributed products business while significantly decreasing global footprint outside the United States. The company focuses on U.S. hereditary cancer testing and clinical diagnostics where it has demonstrated strong growth potential.
Competitive Landscape
Pro stress-test →One of Invitae's 10 competitors is Myriad Genetics, a Corporation company based in Salt Lake City, UT. The genetic diagnostics market includes other clinical laboratory testing providers focused on hereditary cancer and genetic disorders. Invitae competes on test accuracy, turnaround time, and breadth of hereditary disease coverage.
Industry Context
Invitae Corp operates in Clinical genetic diagnostics and testing.
Key facts
Founded: 2010 · Headquarters: San Francisco, US · Employees: N/A · Revenue: Q3 2023: $121.2 million · Market cap: N/A